Total Payments
$64,513
2024 Payments
$6,706
Companies
6
Transactions
53
Payment Breakdown by Category
Consulting$54,373 (84.3%)
Travel$5,786 (9.0%)
Other$2,483 (3.8%)
Research$999.67 (1.5%)
Food & Beverage$872.27 (1.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $54,373 | 15 | 84.3% |
| Travel and Lodging | $5,786 | 22 | 9.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,483 | 1 | 3.8% |
| Unspecified | $999.67 | 2 | 1.5% |
| Food and Beverage | $872.27 | 13 | 1.4% |
Payments by Type
General
$63,513
51 transactions
Research
$999.67
2 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $49,059 | 42 | $0 (2024) |
| PFIZER INC. | $5,656 | 3 | $0 (2024) |
| Agios Pharmaceuticals, Inc. | $5,590 | 4 | $0 (2024) |
| Global Blood Therapeutics, Inc. | $2,620 | 2 | $0 (2021) |
| Bio Products Laboratory USA, Inc. | $1,500 | 1 | $0 (2021) |
| Vertex Pharmaceuticals Incorporated | $87.68 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $6,706 | 5 | PFIZER INC. ($5,656) |
| 2023 | $2,750 | 2 | Agios Pharmaceuticals, Inc. ($2,750) |
| 2022 | $2,488 | 2 | Agios Pharmaceuticals, Inc. ($2,400) |
| 2021 | $11,646 | 12 | Novartis Pharmaceuticals Corporation ($7,526) |
| 2020 | $13,115 | 2 | Novartis Pharmaceuticals Corporation ($13,115) |
| 2019 | $20,864 | 24 | Novartis Pharmaceuticals Corporation ($20,864) |
| 2018 | $6,944 | 6 | Novartis Pharmaceuticals Corporation ($6,944) |
All Payment Transactions
53 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/15/2024 | PFIZER INC. | VYNDAMAX (Drug) | Consulting Fee | Cash or cash equivalent | $5,625.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/07/2024 | PFIZER INC. | OXBRYTA (Drug) | Food and Beverage | In-kind items and services | $5.20 | General |
| Category: HEMATOLOGY | ||||||
| 05/28/2024 | Novartis Pharmaceuticals Corporation | ADAKVEO (Drug) | Consulting Fee | Cash or cash equivalent | $610.00 | General |
| Category: Hematology | ||||||
| 04/16/2024 | PFIZER INC. | OXBRYTA (Drug) | Food and Beverage | In-kind items and services | $25.94 | General |
| Category: HEMATOLOGY | ||||||
| 01/17/2024 | Agios Pharmaceuticals, Inc. | PYRUKYND (Drug) | Consulting Fee | Cash or cash equivalent | $440.00 | General |
| Category: Genetically Defined Disease | ||||||
| 12/20/2023 | Agios Pharmaceuticals, Inc. | PYRUKYND (Drug) | Consulting Fee | Cash or cash equivalent | $1,650.00 | General |
| Category: Genetically Defined Disease | ||||||
| 11/01/2023 | Agios Pharmaceuticals, Inc. | PYRUKYND (Drug) | Consulting Fee | Cash or cash equivalent | $1,100.00 | General |
| Category: Genetically Defined Disease | ||||||
| 08/25/2022 | Vertex Pharmaceuticals Incorporated | — | Food and Beverage | In-kind items and services | $87.68 | General |
| 05/18/2022 | Agios Pharmaceuticals, Inc. | PYRUKYND (Drug) | Consulting Fee | Cash or cash equivalent | $2,400.00 | General |
| Category: Genetically Defined Disease | ||||||
| 12/22/2021 | Novartis Pharmaceuticals Corporation | — | Consulting Fee | Cash or cash equivalent | $610.00 | General |
| 08/18/2021 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Consulting Fee | Cash or cash equivalent | $2,585.00 | General |
| Category: SICKLE CELL DISEASE | ||||||
| 08/18/2021 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Food and Beverage | Cash or cash equivalent | $35.00 | General |
| Category: SICKLE CELL DISEASE | ||||||
| 07/25/2021 | Novartis Pharmaceuticals Corporation | — | Consulting Fee | Cash or cash equivalent | $1,220.00 | General |
| 07/16/2021 | Bio Products Laboratory USA, Inc. | Gammaplex (Drug) | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| Category: IVIG | ||||||
| 06/25/2021 | Novartis Pharmaceuticals Corporation | ADAKVEO (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,482.50 | General |
| Category: HEMATOLOGY | ||||||
| 06/25/2021 | Novartis Pharmaceuticals Corporation | ADAKVEO (Biological) | Travel and Lodging | Cash or cash equivalent | $725.12 | General |
| Category: HEMATOLOGY | ||||||
| 06/25/2021 | Novartis Pharmaceuticals Corporation | ADAKVEO (Biological) | Travel and Lodging | In-kind items and services | $190.87 | General |
| Category: HEMATOLOGY | ||||||
| 06/25/2021 | Novartis Pharmaceuticals Corporation | ADAKVEO (Biological) | Food and Beverage | Cash or cash equivalent | $107.55 | General |
| Category: HEMATOLOGY | ||||||
| 06/25/2021 | Novartis Pharmaceuticals Corporation | ADAKVEO (Biological) | Travel and Lodging | Cash or cash equivalent | $32.00 | General |
| Category: HEMATOLOGY | ||||||
| 06/25/2021 | Novartis Pharmaceuticals Corporation | ADAKVEO (Biological) | Food and Beverage | In-kind items and services | $22.69 | General |
| Category: HEMATOLOGY | ||||||
| 06/13/2021 | Novartis Pharmaceuticals Corporation | — | Consulting Fee | Cash or cash equivalent | $2,135.00 | General |
| 11/03/2020 | Novartis Pharmaceuticals Corporation | — | Consulting Fee | Cash or cash equivalent | $3,355.00 | General |
| 02/21/2020 | Novartis Pharmaceuticals Corporation | — | Consulting Fee | Cash or cash equivalent | $9,760.00 | General |
| 12/07/2019 | NOVARTIS PHARMACEUTICALS CORPORATION | ADAKVEO (Biological) | — | In-kind items and services | $745.00 | Research |
| Study: RESEARCH RELATED PUBLICATIONS SUPPORT • Category: HEMATOLOGY | ||||||
| 12/06/2019 | Novartis Pharmaceuticals Corporation | — | Consulting Fee | Cash or cash equivalent | $14,945.00 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| RESEARCH RELATED PUBLICATIONS SUPPORT | NOVARTIS PHARMACEUTICALS CORPORATION | $999.67 | 2 |
About Dr. Jeffrey Lebensburger, DO
Dr. Jeffrey Lebensburger, DO is a Pediatric Hematology-Oncology healthcare provider based in Birmingham, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/15/2008. The National Provider Identifier (NPI) number assigned to this provider is 1295981793.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jeffrey Lebensburger, DO has received a total of $64,513 in payments from pharmaceutical and medical device companies, with $6,706 received in 2024. These payments were reported across 53 transactions from 6 companies. The most common payment nature is "Consulting Fee" ($54,373).
Ad
Practice Information
- Specialty Pediatric Hematology-Oncology
- Other Specialties Pediatrics, Pediatric Hematology-Oncology
- Location Birmingham, AL
- Active Since 08/15/2008
- Last Updated 03/01/2011
- Taxonomy Code 2080P0207X
- Entity Type Individual
- NPI Number 1295981793
Products in Payments
- ADAKVEO (Biological) $8,978
- CRIZANLIZUMAB (Biological) $6,944
- VYNDAMAX (Drug) $5,625
- PYRUKYND (Drug) $5,590
- OXBRYTA (Drug) $2,651
- Gammaplex (Drug) $1,500
- ADAKVEO (Drug) $610.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatric Hematology-Oncology Doctors in Birmingham
Julie Kanter Washko, Md, MD
Pediatric Hematology-Oncology — Payments: $358,287
Pediatric Hematology-Oncology $358,287
Todd Cooper, D.o, D.O
Pediatric Hematology-Oncology — Payments: $188,792
Pediatric Hematology-Oncology $188,792
Frederick Goldman, Md, MD
Pediatric Hematology-Oncology — Payments: $123,247
Pediatric Hematology-Oncology $123,247
Elna Saah, Md, MD
Pediatric Hematology-Oncology — Payments: $26,107
Pediatric Hematology-Oncology $26,107
Hope Wilson, Md, MD
Pediatric Hematology-Oncology — Payments: $9,794
Pediatric Hematology-Oncology $9,794
Joseph Chewning, M.d, M.D
Pediatric Hematology-Oncology — Payments: $6,081
Pediatric Hematology-Oncology $6,081